rs564747350
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The ENST00000287957.5(GATAD1):c.604G>A(p.Ala202Thr) variant causes a missense change. The variant allele was found at a frequency of 0.0000798 in 1,591,894 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A202P) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000287957.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GATAD1 | NM_021167.5 | c.604G>A | p.Ala202Thr | missense_variant | 4/5 | ENST00000287957.5 | NP_066990.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GATAD1 | ENST00000287957.5 | c.604G>A | p.Ala202Thr | missense_variant | 4/5 | 1 | NM_021167.5 | ENSP00000287957 | P1 | |
GATAD1 | ENST00000493878.1 | n.1212G>A | non_coding_transcript_exon_variant | 2/3 | 1 | |||||
GATAD1 | ENST00000465247.1 | n.616G>A | non_coding_transcript_exon_variant | 1/2 | 2 | |||||
GATAD1 | ENST00000645746.1 | c.*195G>A | 3_prime_UTR_variant, NMD_transcript_variant | 5/6 | ENSP00000493785 |
Frequencies
GnomAD3 genomes AF: 0.000151 AC: 23AN: 152054Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000126 AC: 29AN: 230628Hom.: 0 AF XY: 0.000120 AC XY: 15AN XY: 124592
GnomAD4 exome AF: 0.0000722 AC: 104AN: 1439722Hom.: 0 Cov.: 29 AF XY: 0.0000727 AC XY: 52AN XY: 715260
GnomAD4 genome AF: 0.000151 AC: 23AN: 152172Hom.: 0 Cov.: 32 AF XY: 0.000148 AC XY: 11AN XY: 74384
ClinVar
Submissions by phenotype
Dilated cardiomyopathy 2B Uncertain:3
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 10, 2023 | This sequence change replaces alanine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 202 of the GATAD1 protein (p.Ala202Thr). This variant is present in population databases (rs564747350, gnomAD 0.05%). This variant has not been reported in the literature in individuals affected with GATAD1-related conditions. ClinVar contains an entry for this variant (Variation ID: 163499). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt GATAD1 protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Uncertain significance, criteria provided, single submitter | clinical testing | New York Genome Center | Jun 19, 2020 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Jul 23, 2021 | - - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | May 15, 2014 | The Ala202Thr variant in GATAD1 has not been previously reported in individuals with cardiomyopathy or in large population studies. Computational prediction too ls and conservation analysis do not provide strong support for or against an imp act to the protein. In summary, the clinical significance of the Ala202Thr varia nt is uncertain. - |
Cardiovascular phenotype Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 18, 2024 | The p.A202T variant (also known as c.604G>A), located in coding exon 4 of the GATAD1 gene, results from a G to A substitution at nucleotide position 604. The alanine at codon 202 is replaced by threonine, an amino acid with similar properties. This amino acid position is not well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at